Contingent Consideration Payable

6 Months Ended

Jun. 30, 2021

Debt Disclosure [Abstract]

Contingent Consideration Payable 

Contingent Consideration Payable Prior to the sale of the Hospital Products on June 30, 2020, we computed the fair value of the contingent consideration using several significant assumptions and when those assumptions changed, due to underlying market conditions, the fair value of these liabilities changed as well. Each of the underlying assumptions used to determine the fair values of these contingent liabilities could, and often did, change based on adjustments in current market conditions, competition and other factors. Prior to the sale of the Hospital Products, these changes had a material impact on our unaudited condensed consolidated statements of (loss) income and balance sheets. As part of the sale of the Hospital Products on June 30, 2020, the Exela Buyer assumed and will pay, perform, satisfy and discharge the liabilities and obligations of Avadel Legacy and the Company under the Deerfield Royalty Agreement. As of June 30, 2021 and December 31, 2020, the balance of the contingent consideration payable is $0.

The following table summarizes changes to the contingent consideration payable, a recurring Level 3 measurement, for the six-month period ended June 30, 2020:

Contingent Consideration Payable Rollforward:	Balance
Balance, December 31, 2019	$	17,327
Payments of contingent consideration	(4,344)
Fair value adjustments (1)	3,831
Disposition of the Hospital Products	(14,900)
Balance, June 30, 2020	$	1,914

(1) Fair value adjustments are reported as changes in fair value of contingent consideration and other expense - changes in fair value of contingent consideration payable in the unaudited condensed consolidated statements of (loss) income.